Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021 Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …
News
annie-spratt-yiiz4olewg4-unsplash_1

AI test screens for COVID-19 26% faster than lateral flow tests

September 1, 2021 Research and Development

A University of Oxford-led study has shown that COVID-19 screening results were available 45 minutes after patients arrived in the …
News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021 Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …
News

NICE approves life-saving cholesterol drug for NHS

September 1, 2021 Research and Development

NICE has approved the ground-breaking cholesterol-lowering drug inclisiran, made by Novartis, for use on the NHS. This is an option …
News

Malaria sickness could be cut by 70%, study finds

August 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
News

Trial planned to investigate ketamine in treatment-resistant depression

August 25, 2021 Research and Development

HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …
News
mark

Stelis Biopharma appoints Mark Womack as new CEO

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …
Appointment

PureTech appoints Julie Krop as Chief Medical Officer

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …
Appointment

Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …
Appointment
anita_cooper_002

RareCan appoints Dr Anita Cooper as Non-Executive Director

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …
Appointment

Laura Steele appointed President and General Manager for Lilly UK

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland …
Appointment

Medical cannabis: The next innovation in oncology?

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …
Feature
drugcosts-edt-jumbo

Pharma disputes, fines, and the work of the CMA

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …
Feature

One-time gene therapy sees promising results in children with AADC deficiency

August 25, 2021 Research and Development

A pioneering approach to gene therapy delivery has been published in the European Molecular Biology Organization Journal on Wednesday, wherein …
News

Generic asthma inhaler to offer NHS significant savings

August 25, 2021 Research and Development

Luforbec 100/6 pMDI, the first branded generic alternative to Fostair 100/6 pMDI, to treat adult asthma and severe chronic obstructive …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026